Although several obesity treatment guidelines have been published for obesity specialists, many patients report that it is difficult to receive the care they need because the standards for obesity care are so disparate across health care settings.
Over the past two decades, the National Institutes of Health (NIH) invested in two major multi-center studies aimed at obesity prevention in low-income Hispanic and African American children: the Childhood Obesity Prevention and Treatment Research Consortium (COPTR) and the Girls’ Health Enrichment Multisite Studies (GEMS).
Because the human liver filters toxins and redistributes nutrients, it is one of the most important and versatile organs in the human body. While a healthy liver composed of about 5% fat by mass can regenerate when damaged, the accumulation of excess hepatic (liver) fat can impair liver functioning and silently increase an individual’s risk for diabetes, heart disease, and premature death.
When: 8:30 AM-4:00 PM ET | Monday, April 1, 2019
This February we are pleased to join the American Association for Cancer Research in supporting National Cancer Prevention Month. An estimated 1,762,450 new cancer cases will be diagnosed—more than 4,800 each day—and 606,880 cancer deaths will occur in the United States this year. Roughly half of these cancers will be attributable to preventable causes.
The global increase in obesity is a visible marker of serious systemic problems with contemporary food systems, living environments, and social equity.
January 15, 2019: The Redstone Center submitted a public comment urging the U.S. Department of Health and Human Services to include research objectives that seek to:
As fiduciaries of both Medicaid and state employee health insurance programs, state governments bear a large portion of the direct and indirect costs of adult obesity. Reducing the burden of diseases associated with obesity is a goal of many state policymakers, but the resources devoted to achieving this goal—such as comprehensive coverage for evidence-based obesity treatments—are highly variable across jurisdictions and often inadequate.
Expanded coverage for conventional obesity treatment modalities—intensive lifestyle interventions, anti-obesity medications, and bariatric surgery—is a positive development for individuals with obesity. However, there is no one-size-fits-all approach to obesity management, and not all individuals find success with these standard treatments.
Obesity is often seen as a U.S. problem, but it has now moved well beyond US borders. Earlier this month, experts from around the globe shared international perspectives during a National Academy of Medicine workshop addressing the global obesity pandemic. The U.S. may be a leader in its focus on obesity treatment, but we lag behind many other nations when it comes to preventing the disease.
